ProPhase Labs, Inc. (PRPH): Price and Financial Metrics

ProPhase Labs, Inc. (PRPH): $4.90

0.36 (-6.84%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add PRPH to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#354 of 362

in industry

PRPH Price/Volume Stats

Current price $4.90 52-week high $9.94
Prev. close $5.26 52-week low $4.05
Day low $4.90 Volume 62,087
Day high $5.17 Avg. volume 46,780
50-day MA $5.51 Dividend yield N/A
200-day MA $5.22 Market Cap 88.42M

PRPH Stock Price Chart Interactive Chart >


ProPhase Labs, Inc. (PRPH) Company Bio


ProPhase Labs, Inc. manufactures zinc gluconate glycine lozenges and homeopathic gum. The Company's products reduce the duration and severity of common cold symptoms. ProPhase also manufactures nutrition and weight management products.


PRPH Latest News Stream


Event/Time News Detail
Loading, please wait...

PRPH Latest Social Stream


Loading social stream, please wait...

View Full PRPH Social Stream

Latest PRPH News From Around the Web

Below are the latest news stories about PROPHASE LABS INC that investors may wish to consider to help them evaluate PRPH as an investment opportunity.

ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript

ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript November 9, 2023 ProPhase Labs, Inc. misses on earnings expectations. Reported EPS is $-0.3 EPS, expectations were $-0.2. Operator: Good day and welcome the ProPhase Labs Incorporated Third Quarter 2023 Financial Results and Corporate Update. All participants will be in listen-only mode. [Operator Instructions] After today’s […]

Yahoo | November 10, 2023

ProPhase Labs Inc (PRPH) Reports Mixed Q3 Results Amid Strategic Transformations

Financial and Operational Highlights for the Third Quarter of 2023

Yahoo | November 9, 2023

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023

Company sees significant momentum in Pharmaloz, Nebula Genomics and ProPhase BioPharma Pharmaloz Manufacturing plans on track to increase capacity from $10 million to over $75 million in 2024 Indications of demand for entire planned capacity expansion Nebula Genomics opens new, state of the art Whole Genome Sequencing lab in Garden City, NY. Strong indications for demand lead to significant planned capacity expansion. Company to hold a conference call Thursday, November 9, 2023, at 11:00 AM ET G

Yahoo | November 9, 2023

ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time

GARDEN CITY, NY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on Thursday, November 9, 2023, at 11:00 a.m. Eastern time to discuss its results for the third quarter ended September 30, 2023 and provide a business update. A press release detailing these results will be issued prior to the call. ProPhase Labs’ CEO and Chairman of the Board of Directors, Ted Karkus, will h

Yahoo | November 2, 2023

ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.

Pharmaloz plan is to build capacity with a goal to attain a revenue run-rate of $60 to $80 million by year-end 2024, with 20-25% pre-tax net margins and a goal for additional growth thereafter. Garden City, NY, Oct. 17, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, today unveiled the substantial expansion strategy for its wholly-owned subsidiary, Pharmaloz Manufacturing, Inc. (PMI). Pharmaloz is a large loz

Yahoo | October 17, 2023

Read More 'PRPH' Stories Here

PRPH Price Returns

1-mo -16.10%
3-mo -1.01%
6-mo 8.41%
1-year -36.94%
3-year -6.31%
5-year 64.43%
YTD 8.41%
2023 -53.06%
2022 34.31%
2021 -21.90%
2020 365.99%
2019 -37.46%

Continue Researching PRPH

Here are a few links from around the web to help you further your research on ProPhase Labs Inc's stock as an investment opportunity:

ProPhase Labs Inc (PRPH) Stock Price | Nasdaq
ProPhase Labs Inc (PRPH) Stock Quote, History and News - Yahoo Finance
ProPhase Labs Inc (PRPH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!